Free Trial
OTCMKTS:PXXLF

Poxel (PXXLF) Stock Price, News & Analysis

Poxel logo
$0.25 0.00 (0.00%)
As of 04/25/2025

About Poxel Stock (OTCMKTS:PXXLF)

Key Stats

Today's Range
$0.25
$0.25
50-Day Range
$0.25
$0.25
52-Week Range
$0.25
$0.25
Volume
3,300 shs
Average Volume
N/A
Market Capitalization
$7.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.

Receive PXXLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Poxel and its competitors with MarketBeat's FREE daily newsletter.

PXXLF Stock News Headlines

From Social Security to Social Prosperity?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
See More Headlines

PXXLF Stock Analysis - Frequently Asked Questions

Poxel's stock was trading at $0.25 on January 1st, 2025. Since then, PXXLF shares have increased by 0.0% and is now trading at $0.25.
View the best growth stocks for 2025 here
.

Shares of PXXLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:PXXLF
CIK
N/A
Employees
15
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$710,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$7.24 million
Optionable
Not Optionable
Beta
0.53
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:PXXLF) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners